A phase I trial of retroviral BRCA1sv gene therapy in ovarian cancer

Clinical Cancer Research

Volumn 3, Issue 11, 1997, Pages 1959-1968

  Tait, David L ^a   Obermiller, Patrice S ^b   Redlin Frazier, Sheryl ^a   Jensen, Roy A ^b   Welcsh, Piri ^c   Dann, Jamie ^c   King, Mary Claire ^c   Johnson, David H ^b   Holt, Jeffrey T ^b,d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Department of Cell Biology ^*  (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN; VIRUS VECTOR;

ANTIBODY RESPONSE; ARTICLE; CANCER INHIBITION; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE CALCULATION; FEMALE; GENE THERAPY; GENE TRANSFER; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; OVARY CANCER; PERITONITIS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; REOPERATION;

ADULT; AGED; ANIMALS; DNA, VIRAL; FEMALE; GENE THERAPY; GENES, BRCA1; GENETIC VECTORS; HUMANS; MICE; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; REOPERATION; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 0030656171     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Roth, J. A., and Cristiano, R. J. Gene therapy for cancer: what have we done and where are we going? J. Natl. Cancer Inst., 89: 21-39, 1997.
2. Hall, J. M., Lee, M. K., Newman, B., Morrow, J. E., Anderson, L. A., Huey, B., and King, M-C. Linkage of early-onset breast cancer to chromosome 17q21. Science (Washington DC), 250: 1684-1689, 1990.
3. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. H. A strong candidate gene for the breast and ovarian cancer susceptibility gene BRCA1. Science (Washington DC), 266: 66-71, 1994.
4. Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J., Miki, Y., Eddington, K., McClure, M., Frye, C., Weaver-Feldhaus, J., Ding, W., Gholami, Z., Soderkvist, P., Terry, L., Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. H. BRCA1 mutations in primary breast and ovarian carcinomas. Science (Washington DC), 266: 120-122, 1994.
5. Friedman, L. S., Ostermeyer, E. A., Szabo, C. I., Dowd, P., Lynch, E. D., Rowell, S. E., and King, M-C. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat. Genet., 8: 399-404, 1994.
6. Thompson, M. E., Jensen, R. A., Obermiller, P. S., Page, D. L., and Holt, J. T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet., 9: 444-450, 1995.
7. Hosking, L., Trowsdale, J., Nicolai, H., Solomon, E., Foulkes, W., Stamp, G., Signer, E., and Jeffreys, A. A somatic BRCA1 mutation in an ovarian tumour. Nat. Genet., 9: 343-344, 1995.
8. Merajver, S. D., Pham, T. M., Caduff, R. F., Chen, M., Poy, E. L., Cooney, K. A., Weber, B. L., Collins, F. S., Johnston, C., and Frank, T. S. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat. Genet., 9: 439-443, 1995.
9. Takahashi, H., Behbakht, K., McGovern, P. E., Chiu, H-C., Couch, F. J., Weber, B. L., Friedman, L. S., King, M-C., Furusato, M., LiVolsi, V. A., Menzin, A. W., Liu, P. C., Benjamin, I., Morgan, M. A., King, S. A., Rebane, B. A., Cardonick, A., Mikuta, J. J., Rubin, S. C., and Boyd, J. Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res., 55: 2998-3002, 1995.
10. Gayther, S. A., Mazoyer, S., Warren, W., Russell, P. A., Harrington, P. A., Chiano, M., Seal, S., Hamoudi, R., van Rensberg, E. J., Dunning, A. M., Love, R., Evans, G., Easton, D., Clayton, D., Stratton, M. R., and Ponder, B. A. J. Germline mutations of the BRCA1 gene in breast/ ovarian cancer families: evidence for a genotype/phenotype correlation. Nat. Genet., 11: 428-433, 1995.
11. Holt, J. T., Thompson, M. E., Szabo, C., Robinson-Benion, C., Arteaga, C-L., King, M-C., and Jensen, R. A. Growth retardation and tumor inhibition by BRCA1. Nat. Genet., 12: 298-302, 1996.
12. Rao, V. N., Shao, N., Ahmad, M., and Reddy, E. S. Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene, 12: 523-528, 1996.
13. Shao, N., Chai, Y. L., Shyam, E., Reddy, P., and Rao, V. N. Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene, 13: 1-7, 1996.
14. Wilson, C. A., Payton, M. N., Pekar, S. K., Zhang, K., Pacifici, R. E., Gudas, J. L., Thukral, S., Calzone, F. J., Reese, D. M., and Slamon, D. I. BRCA1 protein products: antibody specificity. Nat. Genet., 13: 264-265, 1996.
15. Wilson, C. A., Payton, M. N., Elliott, G. S., Buaas, F. W., Cajulis, E. E., Grosshans, D., Ramos, L., Reese, D. M., Slamon, D. J., and Calzone, F. J. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b. Oncogene, 14. 1-16, 1997.
16. Kinzler, K. W., and Vogelstein, B. Gatekeepers and caretakers. Nature (Lond.), 386: 761-763, 1997.
17. Marquis, S. T., Rajan, J. V., Wynshaw-Boris, A., Xu, J., Yin, G. Y., Abel, K. J., Weber, B. L., and Chodosh, L. A. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat. Genet., 11: 17-26, 1995.
18. Lane, T. F., Deng, C., Elson, A., Lyu, M. S., Kozak, C. A., and Leder, P. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev., 9: 2712-2722, 1995.
19. Hakem, R., de la Pompa, J. L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., Firpo, E., Hui, C. C., Roberts, J., Rossant, J., and Mak, T. W. The tumor suppressor gene Brca1 is required for embryonic proliferation in the mouse. Cell, 85: 1009-1023, 1996.
20. Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., and Livingston, D. M. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell, 88: 265-275, 1997.
21. Ayesh, S. K., Azar, Y., Barghouti, I. I., Ruedi, J. M., Babior, B. M., and Matzner, Y. Purification and characterization of a C5a-inactivating enzyme from human peritoneal fluid. Blood, 85: 3503-3509, 1995.
22. Arteaga, C. L., and Holt, J. T. Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer in nude mice xenografts. Cancer Res., 56: 1098-1103, 1996.
23. Welsh, R. M., Cooper, N. R., Jensen, F. C., and Oldstone, M. B. A. Human serum lysis RNA tumor viruses. Nature (Lond.), 257: 612-614, 1975.
24. Pensiero, M. N., Wysocki, C. A., Nader, K., and Kikuchi, G. E. Development of amphotropic murine retrovirus vectors resistant to inactivation by human serum. Hum. Gene Ther., 7: 1095-1101, 1996.
25. Rother, R. P., Squinto, S. P., Mason, J. M., and Rollins, S. A. Protection of retroviral vector particles in human blood through complement inhibition. Hum. Gene Ther., 6: 429-435, 1995.
26. Jensen, R. A., Thompson, M. E., Szabo, C., Jetton, T., van der Meer, R., Helou, B., Tronick, S. R., Page, D. L., King, M-C., and Holt, J. T. BRCA1 is secreted and exhibits properties of a granin. Nat. Genet., 12: 303-308, 1996.
27. Chen, Y., Chen, C. F., Riley, D. J., Allred, D. C., Chen, P. L., Von Hoff, D., Osborne, C. K., and Lee, W. H. Aberrant subcellular localization of BRCA1 in breast cancer Science (Washington DC), 270: 789-791, 1995.
28. Scully, R., Ganesan, S., Brown, M., De Caprio, J. A., Cannistra, S. A., Feunteun, J., Schnitt, S., and Livingston, D. M. Location of BRCA1 in human breast and ovarian cancer cells. Science (Washington DC), 272: 123-126, 1996.
29. Chapman, M. S., and Verma, I. M. Transcriptional activation by BRCA1. Nature (Lond.), 382: 678-679, 1996.
30. Monteiro, A. N., August, A., and Hanafusa, H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA, 93: 13595-13599, 1996.
31. Arteaga, C. L., and Holt, J. T. Tissue-targeted antisense anti-fos retroviral vector inhibits established breast cancer in nude mice xenografts. Cancer Res., 56: 1098-1103, 1996.
32. Smith, T. M., Lee, M. K., Szabo, C. I., Jerome, N., McEuen, M., Taylor, M., Hood, L., and King, M. C. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res., 6: 1029-1049, 1996.
33. Xu, C-F., Brown, M. A., Chambers, J. A., Griffiths, B., Nicolai, H., and Solomon, E. Distinct transcription start sites generate two forms of BRCA1 mRNA. Hum. Mol. Genet., 4: 2259-2264, 1995.
34. Rother, R. P., Fodor, W. L., Springhorn, J. P., Birks, W. B., Setter, E., Sandrin, M. S., Squinto, S. P., and Rollins, S. A. A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody. J. Exp. Med., 182: 1345-1355, 1995.
35. Rollins, S. A., Birks, C. W., Setter, E., Squinto, S. P., and Rother, R. P. Retroviral vector producer cell killing in human serum by natural antibody and complement: strategies for evading the humoral immune response. Hum. Gene Ther., 7: 619-626, 1996.
36. Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp, B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., Pisters, K. M., Putnam, J. B., Schea, R., Shin, D. M., Walsh, G. L., Dolormente, M. M., Han, C. I., Martin, F. D., Yen, N., Xu, K., Stephens L. C., McDonnell, T. J., Mukhopadhyay, T., and Cai, D. Retroviral mediated wildtype p53 gene transfer to tumors of patients with lung cancer. Nat. Med., 2: 985-991, 1996.